The disruption of the EGFR mutant allele was essential for NSCLC cell killing effect which indicated that the mutant-specific Cas9 allele can effectively differentiate the mutant EGFR allele from the wild-type allele, leading to targeted disruption of the oncogene and cancer cell death. This evidence concerns the gene EGFR and cancer.